These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 35220210)

  • 1. The Complement C3a-C3a Receptor Axis Regulates Epithelial-to-Mesenchymal Transition by Activating the ERK Pathway in Pancreatic Ductal Adenocarcinoma.
    Suzuki R; Okubo Y; Takagi T; Sugimoto M; Sato Y; Irie H; Nakamura J; Takasumi M; Kato T; Hashimoto M; Kobashi R; Hikichi T; Ohira H
    Anticancer Res; 2022 Mar; 42(3):1207-1215. PubMed ID: 35220210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C3a-C3aR signaling promotes breast cancer lung metastasis via modulating carcinoma associated fibroblasts.
    Shu C; Zha H; Long H; Wang X; Yang F; Gao J; Hu C; Zhou L; Guo B; Zhu B
    J Exp Clin Cancer Res; 2020 Jan; 39(1):11. PubMed ID: 31931851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased semaphorin 3c expression promotes tumor growth and metastasis in pancreatic ductal adenocarcinoma by activating the ERK1/2 signaling pathway.
    Xu X; Zhao Z; Guo S; Li J; Liu S; You Y; Ni B; Wang H; Bie P
    Cancer Lett; 2017 Jul; 397():12-22. PubMed ID: 28315433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular C3 Modulates EMT
    Suzuki R; Takagi T; Sugimoto M; Sato Y; Irie H; Yomogida Y; Ohira H
    Anticancer Res; 2022 Dec; 42(12):5743-5750. PubMed ID: 36456148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mobilization studies in mice deficient in either C3 or C3a receptor (C3aR) reveal a novel role for complement in retention of hematopoietic stem/progenitor cells in bone marrow.
    Ratajczak J; Reca R; Kucia M; Majka M; Allendorf DJ; Baran JT; Janowska-Wieczorek A; Wetsel RA; Ross GD; Ratajczak MZ
    Blood; 2004 Mar; 103(6):2071-8. PubMed ID: 14604969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant upregulation of KLK10 promotes metastasis via enhancement of EMT and FAK/SRC/ERK axis in PDAC.
    Cao XY; Zhang XX; Yang MW; Hu LP; Jiang SH; Tian GA; Zhu LL; Li Q; Sun YW; Zhang ZG
    Biochem Biophys Res Commun; 2018 May; 499(3):584-593. PubMed ID: 29621546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
    Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
    J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aristolochic acid I promotes the invasion and migration of hepatocellular carcinoma cells by activating the C3a/C3aR complement system.
    Li Y; Zhu S; Xue M; Jing Y; Liu X; Cai D; Zhao Y; Bian Y; Zhang Z; Zhang L
    Toxicol Lett; 2023 Apr; 378():51-60. PubMed ID: 32898628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hepatitis B virus X protein promotes pancreatic cancer through modulation of the PI3K/AKT signaling pathway.
    Chen Y; Bai X; Zhang Q; Wen L; Su W; Fu Q; Sun X; Lou Y; Yang J; Zhang J; Chen Q; Wang J; Liang T
    Cancer Lett; 2016 Sep; 380(1):98-105. PubMed ID: 27339327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement C3a and C5a receptor blockade modulates regulatory T cell conversion in head and neck cancer.
    Gadwa J; Bickett TE; Darragh LB; Knitz MW; Bhatia S; Piper M; Van Court B; Bhuvane S; Nguyen D; Nangia V; Kleczko EK; Nemenoff RA; Karam SD
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33789881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCR7 regulates Twist to induce the epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma.
    Li K; Xu B; Xu G; Liu R
    Tumour Biol; 2016 Jan; 37(1):419-24. PubMed ID: 26219899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCL18 promotes epithelial-mesenchymal transition, invasion and migration of pancreatic cancer cells in pancreatic ductal adenocarcinoma.
    Meng F; Li W; Li C; Gao Z; Guo K; Song S
    Int J Oncol; 2015 Mar; 46(3):1109-20. PubMed ID: 25502147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
    Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
    World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a selective nonpeptide antagonist of the anaphylatoxin C3a receptor that demonstrates antiinflammatory activity in animal models.
    Ames RS; Lee D; Foley JJ; Jurewicz AJ; Tornetta MA; Bautsch W; Settmacher B; Klos A; Erhard KF; Cousins RD; Sulpizio AC; Hieble JP; McCafferty G; Ward KW; Adams JL; Bondinell WE; Underwood DC; Osborn RR; Badger AM; Sarau HM
    J Immunol; 2001 May; 166(10):6341-8. PubMed ID: 11342658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pseudokinase SgK223 promotes invasion of pancreatic ductal epithelial cells through JAK1/Stat3 signaling.
    Tactacan CM; Phua YW; Liu L; Zhang L; Humphrey ES; Cowley M; Pinese M; Biankin AV; Daly RJ
    Mol Cancer; 2015 Jul; 14():139. PubMed ID: 26215634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement C3a binding to its receptor as a negative modulator of Th2 response in liver injury in trichloroethylene-sensitized mice.
    Wang F; Zha WS; Zhang JX; Li SL; Wang H; Ye LP; Shen T; Wu CH; Zhu QX
    Toxicol Lett; 2014 Aug; 229(1):229-39. PubMed ID: 24974766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulated long noncoding RNA LINC01296 indicates a dismal prognosis for pancreatic ductal adenocarcinoma and promotes cell metastatic properties by affecting EMT.
    Yuan Q; Zhang Y; Feng L; Jiang Y
    J Cell Biochem; 2019 Jan; 120(1):552-561. PubMed ID: 30203487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PUM1 knockdown prevents tumor progression by activating the PERK/eIF2/ATF4 signaling pathway in pancreatic adenocarcinoma cells.
    Dai H; Shen K; Yang Y; Su X; Luo Y; Jiang Y; Shuai L; Zheng P; Chen Z; Bie P
    Cell Death Dis; 2019 Aug; 10(8):595. PubMed ID: 31395860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DJ-1 promotes invasion and metastasis of pancreatic cancer cells by activating SRC/ERK/uPA.
    He X; Zheng Z; Li J; Ben Q; Liu J; Zhang J; Ji J; Yu B; Chen X; Su L; Zhou L; Liu B; Yuan Y
    Carcinogenesis; 2012 Mar; 33(3):555-62. PubMed ID: 22223849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paracrine IL-6 signaling mediates the effects of pancreatic stellate cells on epithelial-mesenchymal transition via Stat3/Nrf2 pathway in pancreatic cancer cells.
    Wu YS; Chung I; Wong WF; Masamune A; Sim MS; Looi CY
    Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):296-306. PubMed ID: 27750041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.